Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praveen T Krishnamurthy

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Experimental and Molecular Pathology|July 28, 2022
NK1 receptor antagonistic effect of 17-trifluoromethyl phenyl trinor prostaglandin F2α on the growth of human breast cancer cell lineMutukuru Mayuri, Praveen T Krishnamurthy, Thangavel Mahalingam Vijayakumar
Indian Journal of Experimental Biology|March 12, 2015
Identification and characterization of a potent anticancer fraction from the leaf extracts of Moringa oleifera LPraveen T Krishnamurthy, Ambalika Vardarajalu, Ashish Wadhwani, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 25, 2018
Pharmacological targets of breast cancer stem cells: a reviewSai Kiran S S Pindiprolu, Praveen T Krishnamurthy, Pavan Kumar Chintamaneni
Advanced Pharmaceutical Bulletin|November 4, 2024
Co-targeting of HMG-Co-A Reductase and Cycloxygenase-2 for the Treatment of Non-small Cell Lung CancerAshutosh Sharma, Ammu V V V Ravi Kiran, Praveen T Krishnamurthy
Advanced Pharmaceutical Bulletin|December 10, 2021
DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC TreatmentMamta Kumari, Praveen T Krishnamurthy, Sai Kiran S S Pinduprolu, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancerGarikapati Kusuma Kumari, Ammu V V V Ravi Kiran, Praveen T Krishnamurthy
Investigational New Drugs|August 3, 2021
Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancerAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Advanced Pharmaceutical Bulletin|April 8, 2024
ChatGPT in Drug Discovery ProcessAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Nanomedicine (London, England)|July 4, 2020
Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancerSai Kiran Ss Pindiprolu, Praveen T Krishnamurthy, Venkata Rao Ghanta, et al.
Chemistry and Physics of Lipids|January 1, 2021
DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancerSai Kiran S S Pindiprolu, Praveen T Krishnamurthy, Chetan Dev, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Experimental and Molecular Pathology|July 28, 2022
NK1 receptor antagonistic effect of 17-trifluoromethyl phenyl trinor prostaglandin F2α on the growth of human breast cancer cell lineMutukuru Mayuri, Praveen T Krishnamurthy, Thangavel Mahalingam Vijayakumar
Indian Journal of Experimental Biology|March 12, 2015
Identification and characterization of a potent anticancer fraction from the leaf extracts of Moringa oleifera LPraveen T Krishnamurthy, Ambalika Vardarajalu, Ashish Wadhwani, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 25, 2018
Pharmacological targets of breast cancer stem cells: a reviewSai Kiran S S Pindiprolu, Praveen T Krishnamurthy, Pavan Kumar Chintamaneni
Advanced Pharmaceutical Bulletin|November 4, 2024
Co-targeting of HMG-Co-A Reductase and Cycloxygenase-2 for the Treatment of Non-small Cell Lung CancerAshutosh Sharma, Ammu V V V Ravi Kiran, Praveen T Krishnamurthy
Advanced Pharmaceutical Bulletin|December 10, 2021
DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC TreatmentMamta Kumari, Praveen T Krishnamurthy, Sai Kiran S S Pinduprolu, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancerGarikapati Kusuma Kumari, Ammu V V V Ravi Kiran, Praveen T Krishnamurthy
Investigational New Drugs|August 3, 2021
Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancerAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Advanced Pharmaceutical Bulletin|April 8, 2024
ChatGPT in Drug Discovery ProcessAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Nanomedicine (London, England)|July 4, 2020
Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancerSai Kiran Ss Pindiprolu, Praveen T Krishnamurthy, Venkata Rao Ghanta, et al.
Chemistry and Physics of Lipids|January 1, 2021
DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancerSai Kiran S S Pindiprolu, Praveen T Krishnamurthy, Chetan Dev, et al.
Pageof 3